Share

January 22, 2019; 92 (4) Editorial

Stroke prevention

How low can you go?

Steven K. Feske, Cheryl Bushnell
First published December 26, 2018, DOI: https://doi.org/10.1212/WNL.0000000000006802
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
146

Share

Article Information

vol. 92 no. 4 159-160
DOI: 
https://doi.org/10.1212/WNL.0000000000006802
PubMed: 
30587517
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published December 26, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Steven K. Feske, MD and
    2. Cheryl Bushnell, MD, MHS
  1. Steven K. Feske, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Office Practice of Neurology, 2nd ed; Elsevier Science, 2003

    Employment, Commercial Entity:

    1. Brigham and Women's Physician Organization

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen for CHARM trial. I am a coinvestigator in the CHARM trial sponsored by Biogen; I receive no direct compensation from Biogen.

    Research Support, Government Entities:

    1. NIH NeuSTART 2 trial NIH ATACH-II trial NIH STROKENET New England Regional Coordinating Center NIH POINT trial DEFUSE 3 trial ARCADIA trial

    Research Support, Academic Entities:

    1. Columbia Univeristy Medical Center Neurology Department (subcontract for NeuSTART 2 trial and ARCADIA trial)

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Cheryl Bushnell, MD, MHS
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. World Federation of Neurology grant-in-aid

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (S.K.F.), Harvard Medical School; Neurology Department (S.K.F.), Stroke Division, Brigham and Women's Hospital, Boston, MA; and Department of Neurology (C.B.), Stroke Division, Wake Forest Baptist Health, Winston-Salem, NC.
  1. Correspondence
    Dr. Feske sfeske{at}bwh.harvard.edu
View Full Text

Article usage

Article usage: December 2018 to April 2022

AbstractFullPdfSource
Dec 2018180017Highwire
Jan 20197905456Highwire
Feb 20191591712Highwire
Mar 201913899Highwire
Apr 20196536Highwire
May 201911542Highwire
Jun 20197114Highwire
Jul 20195410Highwire
Aug 20194744Highwire
Sep 20195000Highwire
Oct 20198011Highwire
Nov 20195422Highwire
Dec 20194702Highwire
Jan 20204322Highwire
Feb 20205131Highwire
Mar 20203310Highwire
Apr 20203632Highwire
May 20201812Highwire
Jun 20203102Highwire
Jul 20202212Highwire
Aug 20202501Highwire
Sep 20202412Highwire
Oct 20202601Highwire
Nov 20203313Highwire
Dec 20203013Highwire
Jan 20211911Highwire
Feb 20212911Highwire
Mar 20212331Highwire
Apr 20212602Highwire
May 20212302Highwire
Jun 20212600Highwire
Jul 20211710Highwire
Aug 20213400Highwire
Sep 20211810Highwire
Oct 20211200Highwire
Nov 20212300Highwire
Dec 20212901Highwire
Jan 20222340Highwire
Feb 20222410Highwire
Mar 20221812Highwire
Apr 20222810Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me